Latest Breaking News On - National reimbursement drug list - Page 7 : comparemela.com

Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Czech republicUnited statesRafael amadoYajing chenMichael yeeAnupam ramaJosh smileyJack linChristine chiouJonathan changHarald reinhartLinhai zhaoMatt cowperJiajun wenYigal nochomovitzLouise chen

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Macau special administrative regionMacau generalHong kongUnited statesEli lillyZhou yiWeiguo suBen atwell alex shawChinaphase iiibTakeda pharmaceuticals internationalExchange commissionEpizyme incEuropean medicines agencyNational medical products administrationDevices agencyTakeda pharmaceutical company

FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South koreaSouth africaUnited statesMeichiel keenanDavid deluciaAmerican society of hematology annual meetingPancreatic cancer action network phaseExchange commissionNational reimbursement drug listDrug administrationChina health authorityFibrogen incCorporate communicationsGen reports fourth quarterFull yearThane wettig

FibroGen, Inc : FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

FibroGen, Inc : FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South koreaSouth africaUnited statesDavid deluciaMeichiel keenanDrug administrationNational reimbursement drug listCorporate communicationsAmerican society of hematology annual meetingFibrogen incPancreatic cancer action network phaseChina health authorityExchange commissionThane wettigChief executive officerKey highlights

Global Registrational Phase III Study of Olverembatinib (HQP1351) Cleared by FDA

Global Registrational Phase III Study of Olverembatinib (HQP1351) Cleared by FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWestern australiaHong kongPrnewswire ascentage pharmaDajun yangAscentage pharmaMd anderson cancer centerMajor nationalChina national medical products administrationDrug administrationDana farber cancer instituteNational comprehensive cancer networkNational reimbursement drug listGlobal multicenterChronic phase myeloid leukemiaMain board